Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non small-cell lung cancer.
Chan
Geoffrey
G
Pilichowska
Monika
M
D000368:Aged; D018288:Carcinoma, Small Cell / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D000069347:Erlotinib Hydrochloride; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000628:therapy*; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D016609:Neoplasms, Second Primary / Q000473:pathology / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011799:Quinazolines / Q000008:administration & dosage*; D012074:Remission Induction
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride